Skip to content

    CUMBERLAND PHARMACEUTICALS (CPIX) stock price & financials

    View CPIX earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+148.8% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $9.09M
    $10.44M
    $11.71M
    $380.8K
    $8.29M
    -8.7%
    $13.68M
    +31.1%
    $9.13M
    -22.0%
    $166.5K
    -56.3%
    Weakening
    Operating Profit
    -$1.69M
    -$1.84M
    $1.29M
    -$3.12M
    -$1.97M
    -16.0%
    -$1.37M
    +25.6%
    -$3.13M
    -342.2%
    -$3.16M
    -1.3%
    Weakening
    Net Profit
    -$1.54M
    -$1.90M
    $1.26M
    -$740.7K
    -$1.94M
    -25.7%
    -$1.41M
    +25.8%
    -$3.29M
    -361.7%
    -$4.28M
    -477.3%
    Weakening
    EPS
    $-0.11
    $-0.14
    $0.08
    $-0.05
    $-0.13
    -18.2%
    $-0.09
    +35.7%
    $-0.22
    -375.0%
    $-0.29
    -480.0%
    Weakening
    Other Income
    Interest
    $137.4K
    $223.3K
    $163.8K
    $471
    $109.7K
    -20.1%
    $222.0K
    -0.6%
    $85.8K
    -47.6%
    $724
    +53.7%
    Stable
    Depreciation
    Profit before Tax
    -$1.53M
    -$1.96M
    $1.25M
    -$2.99M
    -$1.94M
    -27.4%
    $870.8K
    -$3.14M
    -350.2%
    -$3.10M
    -3.6%
    Weakening
    MarginsOPM
    -18.6%
    -17.6%
    11.0%
    -819.2%
    -23.7%
    -27.1%
    -10.0%
    +43.2%
    -34.3%
    -410.7%
    -1898.7%
    -131.8%
    Weakening
    Tax
    -0.8%
    2.9%
    0.5%
    -0.2%
    -0.3%
    +61.3%
    2.7%
    -8.2%
    -0.1%
    -126.7%
    -0.1%
    +36.8%
    Weakening
    ReturnsROIC
    4.5%
    5.5%
    -3.7%
    2.2%
    5.6%
    +25.7%
    4.1%
    -25.8%
    9.6%
    12.4%
    +477.3%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$27.94M$28.21M$24.75M$27.04M$19.76M$18.32M$17.96M$11.44M$3.86M
    Short-Term Investments$8.29M$0
    Total Current Assets$59.12M$50.16M$49.97M$45.69M$45.87M$35.71M$36.45M$37.06M$33.64M
    Net PP&E$771.2K$3.71M$2.60M$1.47M$5.50M$7.04M$6.45M$6.05M$7.53M
    Goodwill$784.0K$882.0K$882.0K$882.0K$914.0K$914.0K$914.0K$914.0K
    Intangibles$33.66M$30.92M$28.12M$23.95M$30.59M$22.61M$17.97M$53.6K$43.8K
    Total Assets$112.69M$104.55M$96.46M$84.46M$92.93M$81.78M$75.58M$76.82M$62.88M
    LiabilitiesTotal Current Liabilities$27.80M$24.15M$25.67M$19.28M$28.58M$27.98M$31.62M$36.74M$35.19M
    Short-Term Debt$0$5.10M$0
    Long-Term Debt
    Long-Term Leases$2.08M$1.06M$90.0K$4.59M$5.30M$4.94M$4.47M$4.21M
    Total Liabilities$57.12M$53.46M$49.59M$41.86M$56.95M$52.52M$53.04M$52.28M$45.77M
    EquityCommon Stock & APIC$51.10M$49.91M$49.12M$48.45M$47.47M
    Retained Earnings$4.75M$1.21M-$2.13M-$5.64M-$11.21M-$17.49M-$23.97M-$26.80M-$34.37M
    Total Equity$55.84M$51.12M$46.99M$42.81M$36.27M$29.60M$22.85M$24.88M$17.44M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$3.11M$3.06M$5.42M$6.34M$8.45M$6.09M-$612.2K$4.93M$746.0K
    Cash from Investing-$27.72M$2.30M-$1.76M-$501.9K-$13.67M-$105.7K$57.8K-$4.71M-$5.75M
    Cash from Financing$7.14M-$5.08M-$7.12M-$3.55M-$2.06M-$7.42M$196.9K-$6.75M-$7.22M
    SummaryCapital Expenditure-$455.6K-$246.2K-$140.8K-$103.5K-$102.1K-$281.3K-$66.5K-$97.9K-$62.1K
    Free Cash Flow$2.66M$2.81M$5.27M$6.24M$8.35M$5.81M-$678.6K$4.83M$683.9K
    FCF Margin9.1%8.2%14.1%17.3%19.9%14.7%-1.8%10.9%2.2%

    Ratios